174 related articles for article (PubMed ID: 37442610)
21. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
[TBL] [Abstract][Full Text] [Related]
22. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
[TBL] [Abstract][Full Text] [Related]
24. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR
Front Immunol; 2018; 9():1135. PubMed ID: 29892288
[TBL] [Abstract][Full Text] [Related]
25. ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs.
Nowicka H; Sekrecka A; Blaszczyk K; Kluzek K; Chang CY; Wesoly J; Lee CK; Bluyssen HAR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139463
[TBL] [Abstract][Full Text] [Related]
26. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
28. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
29. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
30. Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.
Morrison MM; Williams MM; Vaught DB; Hicks D; Lim J; McKernan C; Aurisicchio L; Ciliberto G; Simion C; Sweeney C; Cook RS
Oncogene; 2016 Mar; 35(9):1143-52. PubMed ID: 26148232
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
32. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.
Sisci D; Maris P; Cesario MG; Anselmo W; Coroniti R; Trombino GE; Romeo F; Ferraro A; Lanzino M; Aquila S; Maggiolini M; Mauro L; Morelli C; Andò S
Cell Cycle; 2013 Nov; 12(21):3405-20. PubMed ID: 24047697
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
JavanMoghadam S; Weihua Z; Hunt KK; Keyomarsi K
Cell Cycle; 2016 Jun; 15(12):1579-90. PubMed ID: 27049344
[TBL] [Abstract][Full Text] [Related]
34. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
35. CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.
Yi J; Wang L; Hu GS; Zhang YY; Du J; Ding JC; Ji X; Shen HF; Huang HH; Ye F; Liu W
EMBO J; 2023 May; 42(10):e112408. PubMed ID: 37009655
[TBL] [Abstract][Full Text] [Related]
36. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity.
Panchanathan R; Shen H; Zhang X; Ho SM; Choubey D
PLoS One; 2010 May; 5(5):e10868. PubMed ID: 20526365
[TBL] [Abstract][Full Text] [Related]
37. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
Zeng H; Xu W
Genes Dev; 2015 Oct; 29(20):2153-67. PubMed ID: 26494790
[TBL] [Abstract][Full Text] [Related]
38. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
39. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
40. Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
Traboulsi T; El Ezzy M; Dumeaux V; Audemard E; Mader S
Oncogene; 2019 Feb; 38(7):1019-1037. PubMed ID: 30190545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
